Clinical trial TIG-007
Study of EOS884448 alone, and in combination with iberdomide with or without dexamethasone, in participants with relapse or refractory multiple myeloma (TIG-007)
Cancers | |
---|---|
Organ | Myeloma |
Trial status | Trial open for recruitment |
Investigator | |
Trial type |
Interventional with experimental drug
|
Phase | Trial phase 1/2 |
Academic trial | Non |
Sponsor | iTeos |
EudraCT Identifier | 2021-004137-36 |
Inclusion criteria | Progression on last line of treatment, no other therapeutic option |
Last update |